In Vitro/Vivo Activity of Potential MCR-1 Inhibitor in Combination With Colistin Againsts mcr-1-Positive Klebsiella pneumonia

Carbapenem resistance among strains of the nosocomial pathogen Klebsiella pneumoniae is increasing worldwide, causing serious clinical infections and higher mortality rates. Polymyxins are some of the few “last resort” options for treatment of carbapenem-resistant Enterobacteriaceae, including K. pn...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yonglin, Wang, Tingting, Guo, Yan, Liu, Shui, Wang, Jianfeng, Shen, Yingbo, Tang, Shusheng, Wang, Yang, Deng, Xuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057107/
https://www.ncbi.nlm.nih.gov/pubmed/30065720
http://dx.doi.org/10.3389/fmicb.2018.01615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057107/
https://www.ncbi.nlm.nih.gov/pubmed/30065720
http://dx.doi.org/10.3389/fmicb.2018.01615

Ejemplares similares